ODIN PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ODIN PHARMACEUTICALS is $100,000, based on 25 certified filings from FY 2021 to FY 2026. This is 17% lower than the national H-1B median salary of $120,000. Compensation at ODIN PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $80,000 and senior positions reaching $170,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ODIN PHARMACEUTICALS range from $61,818 at the 10th percentile to $170,000 at the 90th percentile, showing a $108,182 spread across experience levels and roles. The 25th percentile is $80,000 and the 75th percentile is $165,000.

Yes, ODIN PHARMACEUTICALS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), ODIN PHARMACEUTICALS filed 1 H-1B labor condition applications with 1 certified and 0 denied, at a median salary of $120,000. Across FY 2021–2026, they have filed 26 total H-1B applications with 25 certified and a 3.8% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. ODIN PHARMACEUTICALS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ODIN PHARMACEUTICALS filed 1 H-1B applications, with 1 certified and 0 denied. Over 5 years of data, ODIN PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ODIN PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 3.8%, with 1 out of 26 applications denied across all years. This translates to a 96.2% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ODIN PHARMACEUTICALS as a potential H-1B sponsor.

This denial rate is higher than average. Applicants should ensure all documentation is thoroughly prepared and work closely with ODIN PHARMACEUTICALS's immigration team.

ODIN PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 25 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ODIN PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ODIN PHARMACEUTICALS:

The most frequently sponsored role is Chemist with 6 filings at a median salary of $80,000. This is followed by Qc Lab Manager (3 filings) and Laboratory Manager, Respiratory Product Testing.

ODIN PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ODIN PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ODIN PHARMACEUTICALS H-1B locations:

The largest H-1B hub for ODIN PHARMACEUTICALS is Somerset, NJ with 25 filings at a median salary of $100,000.

ODIN PHARMACEUTICALS's median H-1B salary has changed by -8% from FY 2021 ($130,000) to FY 2026 ($120,000). Tracking salary trends over time reveals how ODIN PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ODIN PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2021: $130,000 (9 certified)
• FY 2022: $85,000 (7 certified)
• FY 2024: $140,483 (4 certified)
• FY 2025: $116,000 (4 certified)
• FY 2026: $120,000 (1 certified)

Salary levels have remained relatively stable at ODIN PHARMACEUTICALS.

ODIN PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 64% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ODIN PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 80% of positions at Level II or higher, ODIN PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ODIN PHARMACEUTICALS's median H-1B salary of $100,000 is 17% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ODIN PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ODIN PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

ODIN PHARMACEUTICALS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ODIN PHARMACEUTICALS files 20% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 25 certified filings, ODIN PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 3.8% denial rate suggests room for improvement in H-1B application preparation.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.